Becker's Healthcare September 9, 2021
Hannah Mitchell

The Bill & Melinda Gates Foundation and artificial intelligence company Exscientia are partnering to develop a COVID-19 treatment using AI software, CNBC reported Sept. 9.

Four details:

  1. The Gates Foundation and Exscientia said Sept. 8 they have signed a four-year deal valued at up to $70 million. Part of the funding will go toward developing a novel antiviral pill that can be used to treat the novel coronavirus and prevent future pandemics, CNBC reported.
  2. “The ongoing...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Biotechnology, Healthcare System, Investments, Pharma / Biotech, Public Health / COVID, Technology, Trends
Related Articles:
Regulations, Innovations and AI Define This Week in Big Tech
Why health system AI predictions can fail
10 things you may have suspected about AI but didn’t know for sure till now
Meta's new AI assistant is rolling out across WhatsApp, Instagram, Facebook and Messenger
Exclusive: Powerful new AI model accurately converts speech to text, even your company's jargon

Share This Article